Alnylam Pharmaceuticals | Umlaufvermögen

Aktienkurs
332.61
Täglich Wechseln
18.21 5.79%
Monatlich
-6.45%
Jährlich
33.04%
Q1 Prognose
304.65




Umlaufvermögen Veränderung Datum
Acadia Pharmaceuticals USD 1.08B 115.87M 2025-09
Agios Pharmaceuticals USD 942.05M 91.06M 2025-12
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
Amgen USD 29.06B 1.17B 2025-12
Arrowhead Research USD 1.17B 223.75M 2025-12
BioCryst Pharmaceuticals USD 355.68M 42.78M 2025-09
BioMarin Pharmaceutical USD 3.85B 49.21M 2025-09
Incyte USD 5.02B 746.01M 2025-12
Ionis Pharmaceuticals USD 2.52B 58.16M 2025-09
Moderna USD 6.54B 54M 2025-12
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
Novartis USD 28.2B 2.26B 2025-09
PTC Therapeutics USD 2.01B 265.07M 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sanofi EUR 30.95B 8.99B 2025-12
Sarepta Therapeutics USD 2.72B 65.32M 2025-09
Takeda JPY 3.12T 195.82B 2025-12
Tectonic Therapeutic USD 273.24M 17.61M 2025-09
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12
Xencor USD 518.44M 5.29M 2025-09


Alnylam Pharmaceuticals Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.